Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection
RAHWAY, N.J.–(BUSINESS WIRE)-– Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the company will initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection. These new Phase 3 studies will evaluate a once-daily oral combination of doravirine 100 mg
Read More
Zim Maternal Mortality Ratio Declines Further
THE number of maternal deaths per live births, multiplied by a conventional factor of 100,000, also known as Maternal Mortality Rate (MMR), has declined to 363 per 100,000 live births in births in Zimbabwe. By Michael Gwarisa This indicates a 6% decline from the previous 2012 MMR ratio of 525. Presenting Preliminary Findings on Mortality
Read MoreMusasa One Stop Centre Assists 500 GBV Survivors
THE Hopley One Stop Centre being run by Musasa Project through support from the UNFPA and the ministry of Women Affairs, Community Development, has served a total 500 women and girls who experienced GBV and other forms of violence over the past 10 months. By Michael Gwarisa Hopley has a high incidence of GBV as
Read MoreNew UNFPA Regional Director Tours Tariro Clinic and Youth Centre in Hopely
RECENTLY appointed United Nations Population Fund East and Southern Africa (UNFPA-ESA) Regional Director, Ms Lydia Zigomo Nyatsanza who is in the country on a mission visit, has applauded Tariro Clinic and Youth Centre for coming through to offer a range of healthcare services as well as life-skills training to vulnerable groups in Hopley. By Michael
Read More